-
- Daniel G. Coit
- 1Memorial Sloan Kettering Cancer Center;
-
- John A. Thompson
- 2Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance;
-
- Mark R. Albertini
- 3University of Wisconsin Carbone Cancer Center;
-
- Christopher Barker
- 1Memorial Sloan Kettering Cancer Center;
-
- William E. Carson
- 4The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;
-
- Carlo Contreras
- 5University of Alabama at Birmingham Comprehensive Cancer Center;
-
- Gregory A. Daniels
- 6UC San Diego Moores Cancer Center;
-
- Dominick DiMaio
- 7Fred & Pamela Buffett Cancer Center;
-
- Ryan C. Fields
- 8Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;
-
- Martin D. Fleming
- 9St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center;
-
- Morganna Freeman
- 10City of Hope National Medical Center;
-
- Anjela Galan
- 11Yale Cancer Center/Smilow Cancer Hospital;
-
- Brian Gastman
- 12Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;
-
- Valerie Guild
- 13Aim at Melanoma;
-
- Douglas Johnson
- 14Vanderbilt-Ingram Cancer Center;
-
- Richard W. Joseph
- 15Mayo Clinic Cancer Center;
-
- Julie R. Lange
- 16The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;
-
- Sameer Nath
- 17University of Colorado Cancer Center;
-
- Anthony J. Olszanski
- 18Fox Chase Cancer Center;
-
- Patrick Ott
- 19Dana-Farber/Brigham and Women's Cancer Center;
-
- Aparna Priyanath Gupta
- 20Robert H. Lurie Comprehensive Cancer Center of Northwestern University;
-
- Merrick I. Ross
- 21The University of Texas MD Anderson Cancer Center;
-
- April K. Salama
- 22Duke Cancer Institute;
-
- Joseph Skitzki
- 23Roswell Park Comprehensive Cancer Center;
-
- Jeffrey Sosman
- 20Robert H. Lurie Comprehensive Cancer Center of Northwestern University;
-
- Susan M. Swetter
- 24Stanford Cancer Institute;
-
- Kenneth K. Tanabe
- 25Massachusetts General Hospital Cancer Center;
-
- Evan Wuthrick
- 26Moffitt Cancer Center; and
-
- Nicole R. McMillian
- 27National Comprehensive Cancer Network
-
- Anita M. Engh
- 27National Comprehensive Cancer Network
説明
<jats:p>The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cutaneous melanoma have been significantly revised over the past few years in response to emerging data on immune checkpoint inhibitor therapies and BRAF-targeted therapy. This article summarizes the data and rationale supporting extensive changes to the recommendations for systemic therapy as adjuvant treatment of resected disease and as treatment of unresectable or distant metastatic disease.</jats:p>
収録刊行物
-
- Journal of the National Comprehensive Cancer Network
-
Journal of the National Comprehensive Cancer Network 17 (4), 367-402, 2019-04
Harborside Press, LLC